What's Up, Doc? Podcast Por Maurinne Bonnet and Anne-Sophie Bohrer arte de portada

What's Up, Doc?

What's Up, Doc?

De: Maurinne Bonnet and Anne-Sophie Bohrer
Escúchala gratis

Welcome to "What's Up, Doc?" ! This informational interview series is designed to support the professional development needs and career exploration efforts of U-M Postdoctoral Fellows. Each episode features a former U-M Postdoctoral Fellow who will discuss their experience transitioning into their career of choice and share advice to help you navigate your own postdoctoral journey. Created by a U-M Postdoctoral Fellow, for Postdoctoral Fellows, in collaboration with the Office of Postdoctoral Affairs.2026 Economía Exito Profesional
Episodios
  • Path to entrepreneurship with Dr. Daniel Wilinski

    Path to entrepreneurship with Dr. Daniel Wilinski
    Apr 2 2026

    In this episode, Dr. Daniel Wilinski, CEO of Keryx, shares his journey from academia to entrepreneurship. Dr. Wilinski discusses the challenges and rewards of transitioning from running a research lab to leading a biotech company, emphasizing the importance of leveraging academic skills in a business context. He also offers advice to aspiring entrepreneurs, encouraging them to pursue their passions and utilize available resources to propel them forward. The conversation highlights the differences between academic and business environments, focusing on the need for adaptability and continuous learning.

    "The training I received as a postdoc set me up well to run a company."

    Dr. Daniel Wilinski

    Guest

    Daniel Wilinski graduated with a PhD in cellular and molecular biology from the University of Wisconsin in 2015. He completed his postdoctoral training at the University of Michigan in 2024 where he was awarded a National Research Service Award (NRSA) T32 Award and a Pathway to Independence (K99/R00) Award from NIH. Daniel is currently the founder and CEO of Keryx, where he develops breakthrough RNA therapeutics that prevent diabetes at a cellular level. As a fun fact, Daniel taught Biology in Tanzania for 2 years.

    Connect with Daniel on LinkedIn
    Más Menos
    32 m
  • Exploring Biotech Frontiers with Dr. Rita Avelar

    Exploring Biotech Frontiers with Dr. Rita Avelar
    Mar 9 2026
    Join us in this insightful episode as we sit down with Dr. Rita Avelar, a lead scientist at CircNova. Discover her inspiring journey from academia to the forefront of biotech innovation. Dr. Avelar shares her experiences transitioning from a postdoc at the University of Michigan to leading groundbreaking research in RNA therapeutics. Learn about the unique challenges and opportunities in the startup world, the importance of networking, and how diverse experiences can shape a successful career in science. Whether you're an aspiring scientist or curious about the biotech industry, this episode offers valuable insights and advice. Tune in to explore the dynamic world of biotech with Dr. Avelar! "[…] there's definitely a supportive environment and communication that has to happen between you and your postdoctoral mentor in order for them to even know how to help you." Dr. Rita Avelar Guest Rita Avelar obtained her PhD in Molecular and Cellular Pathology from the University of Michigan in 2023. She completed her postdoctoral training at the University of Michigan in 2025, and is now Lead Scientist of Research and Translational Discovery at CircNova. With her team, she aims to leverage their NovaEngine™️AI-platform to discover novel and more durable non-coding RNA therapeutics, to target the undruggable and unlock new treatment options for patients with unmet clinical needs. Connect with Rita on LinkedIn Resources Luck is no Accident: Making the Most of Happenstance in Your Life and Career, book by John D. Krumboltz and Al S. Levin Transcript Anne-Sophie Bohrer Hello everyone and welcome to 'What's Up, Doc?', an initiative developed by the University of Michigan Office of Postdoctoral Affairs. 'What's Up, Doc?' is a professional development interview series created to support the career exploration effort and professional development needs of current U-M postdocs. You will hear from former U-M postdocs discuss their own postdoc experience and share advice on their experience transitioning into their career of choice. We hope you will get the answers you want and need to make an informed decision about your own career. I am Anne-Sophie Bohrer Maurinne Bonnet And I am Maurinne Bonnet. Anne-Sophie Bohrer Today our guest is Doctor Rita Avelar, who completed her postdoc at the University of Michigan in 2025. Rita is now the lead scientist of research and translational discovery at CircNova in Ann Arbor. Welcome Rita and thank you for joining us. Rita Avelar Thank you for having me. It's a pleasure to be here. Maurinne Bonnet Hi Rita, welcome. Before we dive into what you actually do in your new job, could you please introduce yourself and, with a bit of your background, how did you end up doing your postdoc at the U of M? Rita Avelar Yeah. So I started my postdoc right after I graduated from my PhD, also at the University of Michigan. I did my PhD with Doctor DiFeo in the pathology department and it felt like the right fit for me to stay a little longer to continue the project that I had during my PhD to see it published and also to expand my expertise from this lab and actually leverage their collaborations at the time, which actually led me to the job that I have today. Anne-Sophie Bohrer So you work for CircNova. Can you tell us a little bit about that company and what they do? Rita Avelar Yeah. So CircNova is actually a biotech that is located in Ann Arbor here in Michigan. And what we do, we use our AI driven drug discovery to accelerate the development of RNA therapeutics. So what that really means is that we are using our proprietary AI Nova engine technology in order to help us predict the RNA structure, binding affinities and biological function to help us engineer new medicines and therapeutic approaches and hope to treat human disease. Anne-Sophie Bohrer Very cool. So like I said earlier, you're the lead scientist. So can you tell us a little bit about what this role entails, what it's like, what it looks like day-to-day? Rita Avelar Yeah. So as the lead scientist, what I really do is to establish and direct all CircNova's experimental biology programs and platforms. So what I really do, and what I'm responsible to do, is to bridge the molecular biology in human disease with the drug discovery to accelerate CircNova's pipeline from early stage innovation to hopefully translational discovery. So my day-to-day really is to help design, execute, and oversee the wet lab research. So I seek to validate all the RNA therapeutics that are generated through our AI and then advance the discovery platforms and introduce the therapeutic programs that we have in collaboration with other biotechs as well as academic institutions. Anne-Sophie Bohrer So it seems that you collaborate with a lot of people. So how many people work at CircNova? Rita Avelar Yeah. So we actually are a smaller biotech right now. We've been around for about two years and right now we are a total of 11 employees. Anne-Sophie Bohrer...
    Más Menos
    31 m
  • Building a Career in Tech Transfer: Insights from Dr. Megan Griffin

    Building a Career in Tech Transfer: Insights from Dr. Megan Griffin
    Mar 9 2026
    Megan Griffin holds a BS in Biotechnology and Molecular Biology from Michigan State University and obtained her PhD in Developmental and Molecular Biology from the University of Cincinnati. She completed her postdoctoral training at the University of Michigan in 2020 and later was an U-M Innovation Partnerships fellow from 2020 to 2022. Megan is now the Assistant Director of Licensing at U-M Innovation Partnerships. In her role, she guides U-M innovators through the process of protecting their intellectual property and commercializing it through licensing to an interested company or creating a new startup venture. Connect with Megan on LinkedIn Resources U-M Innovation Partnerships miLEAD Consulting GroupNucleateNSF I-Corps program Transcript Anne-Sophie Bohrer Hello everyone and welcome to 'What's Up, Doc?', an initiative developed by the University of Michigan Office of Postdoctoral Affairs. 'What's Up, Doc?' is a professional development interview series created to support the career exploration efforts and professional development needs of current U-M postdocs. You will hear from former U-M postdocs discuss their own postdoc experience and share advice on their experience transitioning into their career of choice. We hope you will get the answers you want and need to make an informed decision about your own career. I am Anne-Sophie Bohrer Maurinne Bonnet And I am Maurinne Bonnet. Anne-Sophie Bohrer Today, our guest is Doctor Megan Griffin, who completed her postdoc at the University of Michigan in 2020. Megan is now working at the University of Michigan Innovation Partnerships as an Assistant Director of licensing. Welcome, Megan, and thank you for joining us. Megan Griffin Thank you for having me. Maurinne Bonnet Hey, Megan, it's a pleasure to have you today. So as Anne-Sophie said, you are currently working at Innovation Partnerships, so for some, some of us who are not familiar with that, could you briefly tell us more about this office, what are its main missions, what what are you doing there? Megan Griffin Sure. Yeah. So Innovation Partnerships was recently rebranded, used to be the Office of Technology Transfer here at the University of Michigan. And we rebranded really to capture a wider array of things that we do. So we're sort of divided into 3 branches. I work with the licensing team, we have a ventures team and we have our corporate and foundation research alliances team. So collectively, all of these groups work closely together, and our overall mission is really to help faculty or students or staff, whoever at the university that has innovative research, get that research out to the public. So really our our core mission statement is that we want every piece of research at the University of Michigan have the opportunity to impact the world. So we do this by helping to protect intellectual property that can be in the form of patents or copyrights or, you know, sometimes we can license things without protection, and then we also will try to get it to the world, either through licensing that to companies, help people create their own startup companies, uhm connect people with funding resources, that's another thing we do. So we have a couple of internal translation funds that we manage that are meant to fund the gaps in research to get it to a point where it's ready to be commercialized. And we also have investment funds for creating startup ventures. Uhm, so it's kind of, you know, overall the overarching goal of our office. And if you want to know more about the specific branches, I can get into more detail. Anne-Sophie Bohrer Cool. Well, that's really interesting. Uhm, so clearly you're still somehow and somewhat involved with the science, uhm, but you're not at the bench anymore, you're not in the lab anymore. And so can you tell us a little bit about your background and really what led you to choose to pursue this career? Megan Griffin Yeah, absolutely. So my background is in life sciences, I got a PhD at the University of Cincinnati in molecular and developmental biology. As I was wrapping up my graduate career, I was starting to think about what I wanted to do overall and I hadn't really quite settled on a career path. That was the first time I heard of tech transfer and I thought" Huh, that sounds kind of interesting, let me find out more." So I met with the tech transfer office at the Children's Hospital where I was doing my research, and sort of found out more about the career, but at that point I was about to graduate, it was a little late to get involved with them, uhm, and they told me that, you know, some schools have these internship opportunities available that you might be able to do if you choose to do a postdoc or something like that or maybe you can directly apply. So I decided to do a postdoc to keep my options open, so to speak. I hadn't totally ruled out the traditional route of, uhm, you know, trying to get a professor position, uhm, but I was sort of leaning ...
    Más Menos
    27 m
Todavía no hay opiniones